Avatrombopag latest price in 2023

Avatrombopag (Avatrombopag) is used to treat thrombocytopenia (a low platelet [type of blood cell needed for clotting]) in people with chronic (ongoing) liver disease who are scheduled to have medical or dental procedures to help prevent bleeding complications. It is also used to treat thrombocytopenia in people with chronic immune thrombocytopenia (ITP; an ongoing disorder that may cause abnormal bruising or bleeding due to an abnormally low number of platelets in the blood) who are not helped by other treatments.

Avatrombopag belongs to a class of drugs called thrombopoietin (TPO) receptor agonists, which work by causing the body to produce more platelets. AvatrombopagAn oral tablet after approval for marketing. For the treatment of thrombocytopenia in patients with chronic liver disease scheduled for surgery, it is usually taken once daily with food for 5 days, starting 10 to 13 days before surgery. For the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia, it is usually taken once daily with food whenever directed. Take atrombopag at about the same time each day.

The original drug of avatrombopag has been launched in China and has entered the scope of Class B medical insurance, but it is only reimbursed for eligible patients. The price of a common specification of 20mg*15 tablets may be more than 7,000 yuan per box, while the original drug of avatrombopag marketed overseas is even more expensive. It is understood that there are generic drugs of avatrombopag available overseas, and their pharmaceutical ingredients are basically the same as those of the original drug. For example, the price of a box of 20mg*30 tablets in Laos pharmaceutical production specifications may be around RMB 1,000 (the price may fluctuate due to exchange rates).